Related Experiment Video
Updated: Mar 7, 2026
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
556
Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches
Bincy P Abraham1, Tasneem Ahmed2, Tauseef Ali3
1Houston Methodist Hospital/Weill Cornell Medical College, Houston, TX, USA.
Handbook of Experimental Pharmacology
|February 25, 2017
Summary
Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic gastrointestinal disorders. This review covers current therapies, focusing on novel anti-integrin treatments and treatment algorithms to manage IBD effectively.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- Inflammatory bowel diseases (IBD), primarily Crohn's disease (CD) and ulcerative colitis (UC), are chronic immune-mediated gastrointestinal disorders.
- Their development involves complex interactions between genetic, environmental, immune, and gut microbial factors.
Purpose of the Study:
- To review current therapeutic strategies for IBD.
- To discuss the mechanisms of action, indications, and side effects of various treatment agents.
- To highlight newer therapies like anti-integrin agents and review therapeutic algorithms for CD and UC.
Main Methods:
- Literature review of existing therapeutic agents for IBD.
- Discussion of novel therapeutic classes, including anti-integrin therapy.
- Analysis of current treatment guidelines and algorithms for managing Crohn's disease and ulcerative colitis.
Main Results:
- Various therapeutic agents exist for managing IBD symptoms and inflammation.
- Anti-integrin therapy shows promise as a beneficial treatment option for both CD and UC.
- Established therapeutic algorithms guide the management of these complex conditions.
Conclusions:
- Effective management of IBD requires a multifactorial therapeutic approach.
- Emerging therapies like anti-integrin agents offer new avenues for treatment.
- Adherence to therapeutic algorithms is crucial for optimizing patient outcomes in IBD.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
874
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
874
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
01:21Inflammatory Bowel Disease V: Surgical Management
785
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
785
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
01:17Chronic Bowel Disorders: Introduction
867
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867